Evidence map›Paper›PMID 33973414›Full record

ReviewArthritis care & research2022

Identifying Potential Classification Criteria for Calcium Pyrophosphate Deposition Disease: Item Generation and Item Reduction.

Sara K Tedeschi, Tristan Pascart, Augustin Latourte, Cattleya Godsave, Burak Kundakci, Raymond P Naden, William J Taylor, Nicola Dalbeth, Tuhina Neogi, Fernando Perez-Ruiz and 28 more

Abstract readReview
In one paragraph

Review in Arthritis care & research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. A Case of Pseudogout in an Adolescent on Isotretinoin.Case reports in rheumatology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review: Outcome measures in calcium pyrophosphate deposition.Best practice & research. Clinical rheumatology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors.

Sara K TedeschiBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.ORCID 0000-0001-9475-1363
Tristan PascartLille Catholic University, Lille, France.ORCID 0000-0002-8395-826X
Augustin LatourteHôpital Lariboisière, Université de Paris, Paris, France.ORCID 0000-0002-1087-7768
Cattleya GodsaveUniversity of Nottingham, Nottingham, UK.
Burak KundakciUniversity of Nottingham, Nottingham, UK.
Raymond P Naden
William J TaylorUniversity of Otago, Wellington, New Zealand.
Nicola DalbethUniversity of Auckland, Auckland, New Zealand.ORCID 0000-0003-4632-4476
Tuhina NeogiBoston University School of Medicine, Boston, Massachusetts.ORCID 0000-0002-9515-1711
Fernando Perez-RuizOsakidetza, Ezkerraldea-Enkarterri-Cruces, Cruces University Hospital, Biocruces-Bizkaia Health Research Institute, and University of the Basque Country, Spain.
Ann RosenthalMedical College of Wisconsin, Milwaukee.
Fabio BecceLausanne University Hospital, Lausanne, Switzerland.ORCID 0000-0001-8444-8504
Eliseo PascualHospital General Universitario de Alicante and Alicante Institute of Sanitary and Biomedical Research, Alicante, Spain.
Mariano AndresHospital General Universitario de Alicante and Alicante Institute of Sanitary and Biomedical Research, Alicante, Spain.
Thomas BardinHôpital Lariboisière, Université de Paris, Paris, France.ORCID 0000-0002-5080-4790
Michael DohertyUniversity of Nottingham, Nottingham, UK.
Hang-Korng EaHôpital Lariboisière, Université de Paris, Paris, France.ORCID 0000-0002-2393-7475
Georgios FilippouLuigi Sacco University Hospital, Milan, Italy.
John FitzGeraldDavid Geffen School of Medicine, University of California, Los Angeles.ORCID 0000-0002-8419-7538
Marwin GuitierrezInstituto Nacional de Rehabilitación, Mexico City, Mexico.ORCID 0000-0002-7995-1110
Annamaria IagnoccoUniversità degli Studi di Torino, Turin, Italy.
Tim L JansenVieCuri Medical Center, Venlo, Noord-Limburg, and University of Twente, Enschede, The Netherlands.
Minna J KohlerMassachusetts General Hospital and Harvard Medical School, Boston.
Frédéric LiotéHôpital Lariboisière, Université de Paris, Paris, France.
Mark MatzaMassachusetts General Hospital and Harvard Medical School, Boston.
Geraldine M McCarthyMater Misericordiae University Hospital, Dublin, Ireland.
Roberta RamondaUniversity of Padova, Padova, Italy.ORCID 0000-0002-9683-8873
Anthony M ReginatoBrown University, Providence, Rhode Island.
Pascal RichetteHôpital Lariboisière, Université de Paris, Paris, France.
Jasvinder A SinghUniversity of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center.
Francisca SiveraHospital General Universitario Elda, Elda, and Universidad Miguel Hernandez, Elche, Spain.
Alexander SoLausanne University Hospital, Lausanne, Switzerland.
Lisa K StampUniversity of Otago, Christchurch, New Zealand.ORCID 0000-0003-0138-2912
Janeth YinhMassachusetts General Hospital and Harvard Medical School, Boston.
Chio YokoseMassachusetts General Hospital and Harvard Medical School, Boston.ORCID 0000-0001-7557-3303
Robert TerkeltaubSan Diego Veterans Administration Healthcare Service and University of California-San Diego.ORCID 0000-0001-5368-7473
Hyon ChoiMassachusetts General Hospital and Harvard Medical School, Boston.
Abhishek AbhishekUniversity of Nottingham, Nottingham, UK.

Funding

The Effects of Urate Lowering Therapy on Inflammation, Endothelial function, andP50AR060772 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SINGH, JASVINDER A · 2012 to 2021
$12.8M
Research and Evaluation Support Core Unit (RESCU Core)P30AR072571 · NIAMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI TUHINA NEOGI · 2019 to 2026
$6.9M
Research Training in Rheumatology at Massachusetts General HospitalT32AR007258 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI ANDREW D LUSTER · 1986 to 2026
$6.9M
The Role of Urate in Knee Osteoarthritis-Related Inflammation, Pathology and PainK24AR070892 · NIAMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI TUHINA NEOGI · 2017 to 2026
$1.1M
Studying pseudogout using naturallanguage processing and novelimaging approachesK23AR075070 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI TEDESCHI, SARA K. · 2019 to 2023
$937k
Novel Synovial Role in Pathogenesis of GoutR21AR075990 · NIAMS · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI TERKELTAUB, ROBERT A. · 2019 to 2020
$333k
NIAMS NIH HHS K23 AR075070NIAMS NIH HHS K24 AR070892NIAMS NIH HHS L30 AR070514NIAMS NIH HHS P30 AR072571NIAMS NIH HHS P50 AR060772NIAMS NIH HHS R21 AR075990NIAMS NIH HHS T32 AR007258
6 · The paper itself

Abstract

objectiveClassification criteria for calcium pyrophosphate deposition (CPPD) disease will facilitate clinical research on this common crystalline arthritis. Our objective was to report on the first 2 phases of a 4-phase process for developing CPPD classification criteria.

methodsCPPD classification criteria development is overseen by a 12-member steering committee. Item generation (phase I) included a scoping literature review of 5 literature databases and contributions from a 35-member combined expert committee and 2 patient research partners. Item reduction and refinement (phase II) involved a combined expert committee meeting, discussions among clinical, imaging, and laboratory advisory groups, and an item-rating exercise to assess the influence of individual items toward classification. The steering committee reviewed the modal rating score for each item (range -3 [strongly pushes away from CPPD] to +3 [strongly pushes toward CPPD]) to determine items to retain for future phases of criteria development.

resultsItem generation yielded 420 items (312 from the literature, 108 from experts/patients). The advisory groups eliminated items that they agreed were unlikely to distinguish between CPPD and other forms of arthritis, yielding 127 items for the item-rating exercise. Fifty-six items, most of which had a modal rating of +/- 2 or 3, were retained for future phases. As numerous imaging items were rated +3, the steering committee recommended focusing on imaging of the knee and wrist and 1 additional affected joint for calcification suggestive of CPP crystal deposition.

conclusionA data- and expert-driven process is underway to develop CPPD classification criteria. Candidate items comprise clinical, imaging, and laboratory features.

Indexed as

ChondrocalcinosisCrystal ArthropathiesCalcium PyrophosphateHumansKnee JointWrist JointCalcium Pyrophosphate

Identifiers

PMID33973414
PMCPMC8578594

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.